This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Kanegafuchi Kagaku Kogyo Kabushiki Kaisha. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: The Innovations of Shinichi Aotsuka
Introduction
Shinichi Aotsuka is a notable inventor based in Shonan, Japan. He has made significant contributions to the field of medical technology, particularly in the area of autoantibody removal. His innovative work has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Aotsuka holds a patent for an "Autoantibody adsorbent and apparatus for removing autoantibodies using." This invention involves an adsorbent designed for autoantibodies or immune complexes, which is produced by combining an autoantibody with its homologous antigen. The adsorbent comprises a water-insoluble porous material and a compound with an anionic functional group immobilized onto the material. The apparatus allows for the selective removal of autoantibodies or immune complexes from body fluids without eliminating useful components. This innovation is crucial for improving patient outcomes in various medical conditions.
Career Highlights
Shinichi Aotsuka is associated with Kanegafuchi Kagaku Kogyo Kabushiki Kaisha, where he has been able to apply his expertise in developing advanced medical solutions. His work has garnered attention for its potential impact on healthcare practices.
Collaborations
Aotsuka has collaborated with notable colleagues, including Ryuichi Yokohari and Makiko Kinoshita. Their combined efforts have contributed to the advancement of medical technologies and innovations.
Conclusion
Shinichi Aotsuka's contributions to the field of medical technology through his patent for autoantibody removal demonstrate his commitment to improving healthcare solutions. His innovative approach has the potential to significantly enhance patient care and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
